Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs5742904
rs5742904
0.800 GeneticVariation BEFREE Population studies suggest that approximately 0.1% of Northern Europeans and US Caucasians carries the R3500Q variant in APOB most commonly associated with FDB; in addition, the APOB R3500 W variant is known to make a significant contribution to familial hypercholesterolemia (FH) among East Asians. 27919345

2017

dbSNP: rs5742904
rs5742904
T 0.800 CausalMutation CLINVAR Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically. 27765764

2016

dbSNP: rs5742904
rs5742904
0.800 GeneticVariation BEFREE The FH chip contains the APOB mutation p.Arg3527Gln, all 89 LDLR point mutations and small DNA rearrangements detected in Czech FH patients, and 78 mutations frequent in other European and Asian FH populations. 21310417

2011

dbSNP: rs5742904
rs5742904
0.800 GeneticVariation BEFREE The R3500Q and R3531C mutations are absent in our probands and for 1 proband, the implication of LDLR, APOB and PCSK9 genes was excluded, supporting the implication of a fourth gene in the determination of FH. 16806138

2006

dbSNP: rs5742904
rs5742904
0.800 GeneticVariation BEFREE Mutations in the LDL receptor (LDLR) gene and the R3500Q mutation in the apolipoprotein B (APOB) gene are known to cause FH, but lack of high-throughput methods makes routine genetic diagnosis difficult. 15890894

2005

dbSNP: rs5742904
rs5742904
0.800 GeneticVariation BEFREE In a previous study, we have shown that in patients with definite FH around 20% had no identifiable gene defect after screening the entire exon coding area of the low density lipoprotein receptor (LDLR) and testing for the common Apolipoprotein B (ApoB) R3500Q mutation. 16159606

2005

dbSNP: rs5742904
rs5742904
0.800 GeneticVariation BEFREE In this study, DNA sequencing of the 12 exons of the PCSK9 gene has been performed in 51 Norwegian subjects with a clinical diagnosis of familial hypercholesterolemia where mutations in the low-density lipoprotein receptor gene and mutation R3500Q in the apolipoprotein B-100 gene had been excluded. 15099351

2004

dbSNP: rs5742904
rs5742904
0.800 GeneticVariation BEFREE Few data are available on genotype-phenotype interactions among familial hypercholesterolemia (FH) patients in South European populations and there are no data about the influence of R3500Q mutation on lipoprotein phenotype compared to low-density lipoprotein receptor (LDLR) mutations. 14508510

2003

dbSNP: rs5742904
rs5742904
0.800 GeneticVariation BEFREE In conclusion, the R3500Q mutation of the apolipoprotein B gene, a common cause of FH in central Europe, is infrequent in the general Spanish population, but it is common in Galicia. 12208478

2002

dbSNP: rs5742904
rs5742904
0.800 GeneticVariation BEFREE Frequency of the R3500Q mutation of the apolipoprotein B-100 gene in a sample screened clinically for familial hypercholesterolemia in Hungary. 11137107

2001

dbSNP: rs5742904
rs5742904
0.800 GeneticVariation BEFREE Heterozygous carriers of the Arg3500Gln mutation were significantly more common among patients with ischemic heart disease (odds ratio, 7.0; 95 percent confidence interval, 2.2 to 22; P=0.003) and patients with familial hypercholesterolemia (odds ratio, 78; 95 percent confidence interval, 16 to 388; P=0.001) than in the general population. 9603795

1998

dbSNP: rs5742904
rs5742904
0.800 GeneticVariation BEFREE Hypercholesterolemia clustering in families not explained by either low density lipoprotein (LDL)-receptor mutations producing familial hypercholesterolemia (FH), or the apolipoprotein B (apo B) Arg3500-->Gln mutation with familial defective apo B (FDB), is common in the Finnish population. 9050776

1997

dbSNP: rs5742904
rs5742904
0.800 GeneticVariation BEFREE The apoB Arg3500-->Gln mutation was absent in 228 French Canadians with the FH phenotype. 7554246

1995

dbSNP: rs5742904
rs5742904
0.800 GeneticVariation BEFREE From a sample of 243 patients from Munich with type IIa hyperlipoproteinemia (HL), we have identified eight individuals with the apo B-100 arginine(3500)----glutamine mutation. 2164382

1990